Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer have?
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer has 4,592 citations in the OpenAlex counts ScholarIQ stores.
When was Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer published?
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer has 2017 year in the ScholarIQ index.
What is the open-access status of Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer?
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer has bronze oa status in the ScholarIQ index.
What is the DOI of Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer?
The DOI for Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer is on the source record.
What is the PMID of Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer?
The PMID for Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer is on the source record.
What is the OpenAlex record for Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer?
The OpenAlex for Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer is on the source record.